Business Context and Reporting Period
This Form 8-K Current Report was filed by Inpixon (trading symbol: INPX) on February 12, 2021. The filing details a registered direct offering of common stock and warrants, the termination of an existing at-the-market equity facility, and an exchange of debt for equity. The company is incorporated in Nevada and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics and Capital Structure
- Offering Proceeds: The company expects to receive gross proceeds of approximately $30 million from the registered direct offering, before deducting placement agent fees and expenses.
- Offering Structure: The offering consists of 7,000,000 shares of common stock and warrants to purchase up to 15,000,000 shares at a combined price of $2.00 per share. Additionally, 8,000,000 pre-funded warrants were sold at $1.999 each.
- Debt Reduction: The company executed an exchange agreement to convert $1.5 million of an outstanding unsecured promissory note (originally $6,465,000) into 893,921 shares of common stock at an effective price of $1.678 per share.
- Outstanding Shares: As of February 10, 2021, there were 72,538,276 shares of common stock outstanding. This excludes 3,000,000 shares from warrant exercises and 893,921 shares from the debt exchange pending issuance on February 16, 2021.
- Historical ATM Proceeds: Prior to termination, the company raised approximately $48.5 million in gross proceeds (net of $46.5 million) through its at-the-market facility.
Material Changes Versus Prior Period
- Capital Raise: The company is raising approximately $30 million in new equity capital, a significant liquidity event compared to the prior period.
- Facility Termination: The Equity Distribution Agreement for the at-the-market (ATM) offering, which had a capacity of up to $150 million, was terminated on February 12, 2021.
- Debt-to-Equity Conversion: A portion of the company's debt load was reduced by $1.5 million through conversion to equity, altering the capital structure.
- Ownership Limitations: New purchase warrants and pre-funded warrants include a 9.99% beneficial ownership limitation, which can be adjusted with notice.
Guidance, Outlook, and Risks
- Closing Date: The closing of the registered direct offering is expected to occur on or about February 17, 2021, subject to customary closing conditions.
- Standstill Period: The company agreed to an 85-day standstill period (or until trading volume exceeds $500 million) during which it cannot issue new equity or file new registration statements, with specific exceptions for the debt exchange.
- Placement Agent Fees: Maxim Group LLC was engaged as the exclusive placement agent for a cash fee of 7% of the aggregate gross proceeds.
- Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. There is no assurance that the offering will close, and actual results may differ materially from expectations. The debt exchange is contingent on the shares being approved and held by the investor's brokerage firm.
Investor Verification Checklist
- Verify the final closing date of the offering and the actual net proceeds received after fees.
- Confirm the issuance of the 3,893,921 shares resulting from the warrant exercise and debt exchange on or before February 16, 2021.
- Monitor the 85-day standstill period restrictions on future equity issuances.
- Review the remaining balance of the $6,465,000 promissory note after the $1.5 million conversion.
- Check for any subsequent filings regarding the exercise of the 15,000,000 purchase warrants or 8,000,000 pre-funded warrants.